Geraniol (Synonyms: β-Geraniol, (E)-Geraniol, NSC 9279) |
| Catalog No.GC38685 |
Le géraniol, un terpène oléfinique, s'est avéré inhiber la croissance des souches de Candida albicans et de Saccharomyces cerevisiae.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 106-24-1
Sample solution is provided at 25 µL, 10mM.
Product has been cited by 1 publications
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Geraniol, an olefinic terpene, was found to inhibit growth of Candida albicans and Saccharomyces cerevisiae strains[1].
[1]. Bard M, et al. Geraniol interferes with membrane functions in strains of Candida and Saccharomyces. Lipids. 1988 Jun;23(6):534-8.
| Cas No. | 106-24-1 | SDF | |
| Synonymes | β-Geraniol, (E)-Geraniol, NSC 9279 | ||
| Canonical SMILES | C/C(C)=C\CC/C(C)=C/CO | ||
| Formula | C10H18O | M.Wt | 154.25 |
| Solubility | Insoluble in Water; ≥42.7 mg/mL in DMSO; ≥68 mg/mL in EtOH | Storage | 4°C, protect from light |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 6.483 mL | 32.4149 mL | 64.8298 mL |
| 5 mM | 1.2966 mL | 6.483 mL | 12.966 mL |
| 10 mM | 0.6483 mL | 3.2415 mL | 6.483 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC10739 (S)-HexylHIBO
- GC32474 Mexiletine hydrochloride (KOE-1173 (hydrochloride))
- GC10098 (S)-10-Hydroxycamptothecin
- GC34245 GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
- GC44513 Orfamide A
- GC19613 Cy5 NHS ester(Et)
- GC44626 Phenylacetyl Coenzyme A
- GC10941 cAMPS-Rp, triethylammonium salt
- GC60374 Trovafloxacin
- GC18246 R-59-949
- GC61185 Picropodophyllone
- GC31875 CL656 (c-[2'FdAMP(S)-2'FdIMP(S)])
- GC12055 Milnacipran HCl
- GC18506 N-Arachidonoyl Dopamine
- GC32058 Amelubant (BIIL 284)
- GC36198 Gusperimus trihydrochloride
Avis
Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *